Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue sup1: COTS supplement
Submit an article Journal homepage
409
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the “Cure” in Ocular Tuberculosis

Aniruddha Agarwala Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaORCID Iconhttps://orcid.org/0000-0003-4985-9855View further author information
, MDORCID Icon,
Rupesh Agrawalb Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore;c National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore;d Department of Ophthalmology, Singapore Eye Research Institute, Singapore, Singapore;e Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UKORCID Iconhttps://orcid.org/0000-0002-6662-5850View further author information
, MD, FRCSORCID Icon,
Dhananjay Rajef Department of Statistics, UCL Institute of Ophthalmology, London, UKView further author information
, MSc,
Ilaria Testie Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UKView further author information
, MD,
Sarakshi Mahajang Department of Ophthalmology, MDS Bioanalytics, IndiaView further author information
, MBBS,
Dinesh Visva Gunasekeranb Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore;c National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, SingaporeView further author information
, MBBS,
Kanika Aggarwalf Department of Statistics, UCL Institute of Ophthalmology, London, UKView further author information
, MS,
Somasheila I. Murthyh Byres Eye Institute, Stanford University, Palo Alto, California, USA;i Department of Ophthalmology, Tej Kohli Cornea Institute, LV Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, IndiaView further author information
, MS,
Mark Westcotte Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UK;f Department of Statistics, UCL Institute of Ophthalmology, London, UKView further author information
, FRCOphth,
Soon-Phaik Cheeb Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore;d Department of Ophthalmology, Singapore Eye Research Institute, Singapore, Singapore;j Singapore National Eye Centre, Singapore, Singapore;k Department of Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore City, SingaporeView further author information
, FRCS,
Peter Mccluskeyl Department of Clinical Ophthalmology & Eye Health, Central Clinical School, Save Sight Institute, the University of Sydney, Sydney, AustraliaView further author information
, PhD,
Su Ling Hoc National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, SingaporeView further author information
, MD,
Stephen Teohc National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, SingaporeView further author information
, FRCS,
Luca Ciminom Ocular Immunology Unit, Azienda USL IRCCS, Reggio, ItalyORCID Iconhttps://orcid.org/0000-0001-7956-9950View further author information
, MDORCID Icon,
Jyotirmay Biswasn Department of Ophthalmology, Sankara Nethralaya, Chennai, IndiaView further author information
, MD,
Shishir Naraino Department of Ophthalmology, Shroff Eye Centre, New Delhi, IndiaView further author information
, MD,
Manisha Agarwalp Department of Ophthalmology, Dr Shroff’s Charity Eye Hospital Daryaganj, New Delhi, IndiaView further author information
, MS,
Padmamalini Mahendradasq Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, IndiaView further author information
, DNB,
Moncef Khairallahr Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir, TunisiaView further author information
, MD,
Nicholas Joness Department of Ophthalmology, University of Manchester, Manchester, UKView further author information
, MD,
Ilknur Tugal-Tutkunt Istanbul Faculty of Medicine, Department of Ophthalmology, Istanbul University, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-4020-453XView further author information
, MDORCID Icon,
Kalpana Babuu Prabha Eye Clinic & Research Centre, Vittala International Institute of Ophthalmology, Bangalore, IndiaView further author information
, DNB,
Soumayava Basuv Department of Ophthalmology, LV Prasad Eye Institute, Bhubaneswar, IndiaView further author information
, MD,
Ester Carreñow Department of Ophthalmology, Hospital Universitario Fundacion Jimenez Diaz, Madrid, SpainView further author information
, MD,
Richard Leee Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UKView further author information
, PhD,
Hassan Al-Dhibix Department of Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi ArabiaView further author information
, MD,
Bahram Bodaghiy Department of Ophthalmology, DHU SightRestore, Sorbonne University, Paris, FranceView further author information
,
Alessandro Invernizziz Eye Clinic, Department of Biomedical and Clinical Science “L. Sacco”, Luigi Sacco Hospital, University of Milan, Milan, ItalyORCID Iconhttps://orcid.org/0000-0003-3400-1987View further author information
ORCID Icon,
Debra A. Goldsteinaa Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USAView further author information
,
Carl P. Herbortbb Department of Ophthalmology, Centre for Ophthalmic Specialised Care & University of Lausanne, Lausanne, SwitzerlandView further author information
,
Talin Barisani-Asenbauercc The Centre for Ocular Inflammation and Infection (OCUVAC), Laura Bassi Centre of Expertise Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, AustriaView further author information
,
Julio J. González-Lópezdd Department of Ophthalmology, Ramón Y Cajal University Hospital, Madrid, SpainORCID Iconhttps://orcid.org/0000-0001-7210-7809View further author information
, MDORCID Icon,
Sofia Androudiee Department of Ophthalmology, University of Thessaly, Thessaly, GreeceORCID Iconhttps://orcid.org/0000-0002-5303-7793View further author information
, MDORCID Icon,
Reema Bansala Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaView further author information
, MS,
Bruttendu Moharanaa Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaView further author information
, MS,
Simona Degli Espostie Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UKView further author information
, MD,
Anastasia Tasiopouloue Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UKView further author information
, MD,
Sengal Nadarajahe Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UKView further author information
, MD,
Mamta Agarwaln Department of Ophthalmology, Sankara Nethralaya, Chennai, IndiaView further author information
, DNB,
Sharanya Abrahamn Department of Ophthalmology, Sankara Nethralaya, Chennai, IndiaView further author information
, DNB,
Ruchi Valaq Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, IndiaView further author information
, DNB,
Ramandeep Singha Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaView further author information
, MS,
Aman Sharmaff Department of Rheumatology, PGIMER, Chandigarh, IndiaView further author information
, MD,
Kusum Sharmagg Department of Microbiology, PGIMER, Chandigarh, IndiaView further author information
, MD,
Manfred Zierhuthh Centre of Ophthalmology, Department of Ophthalmology, University of Tuebingen, Tuebingen, GermanyView further author information
, MD, PhD,
Onn Min Konii Chest and Allergy Clinic, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UKView further author information
, PhD,
Emmett T. Cunninghamjj UCSF School of Medicine, The Francis I. Proctor Foundation, San Francisco, California, USAView further author information
, MD,
John H. Kempenkk Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA;ll MCM Eye Unit, MyungSung Christian Medical Center and MyungSung Medical School, Addis Ababa, EthiopiaView further author information
, MD, PhD,
Quan Dong Nguyenh Byres Eye Institute, Stanford University, Palo Alto, California, USAView further author information
, MD, MSc,
Carlos Pavesioe Department of Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust, London, UKView further author information
, FRCOphth &
Vishali Guptaa Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaCorrespondence[email protected]
View further author information
, MS show all
Pages 65-73 | Received 20 Apr 2020, Accepted 23 Apr 2020, Published online: 26 Jun 2020

References

  • Testi I, Agrawal R, Mahajan S, et al. Tubercular uveitis: nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1. Ocul Immunol Inflamm. 2019 November:1–9. doi:10.1080/09273948.2019.1646774.
  • Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the Collaborative Ocular Tuberculosis Study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171.doi:10.1167/iovs.18-24102.
  • Gunasekeran DV, Gupta B, Cardoso J, Pavesio CE, Agrawal R. Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. Ocul Immunol Inflamm. 2018;26(6):865–869. doi:10.1080/09273948.2017.1296580.
  • Basu S, Monira S, Modi RR, et al. Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4(1):3.doi:10.1186/1869-5760-4-3.
  • Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327.doi:10.1001/jamaophthalmol.2017.4485.
  • Agrawal R, Agarwal A, Jabs DA, et al. Standardization of nomenclature for ocular tuberculosis - results of Collaborative Ocular Tuberculosis Study (COTS) workshop. Ocul Immunol Inflamm. 2019 December:1–11. doi:10.1080/09273948.2019.1653933.
  • WHO. WHO | global tuberculosis report 2019. http://www.who.int/tb/publications/global_report/en/. Accessed April 12, 2020.
  • World Health Organization. Treatment of tuberculosis: 2017 update. http://www.tbonline.info/media/uploads/documents/who_guidelines.pdf. Accessed May 7, 2019.
  • Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3:S231–279.
  • Pubmeddev PP, et. al. A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens. PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/29169355. Accessed April 12, 2020.
  • Agrawal R, Gunasekeran DV, Agarwal A, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis. Ocul Immunol Inflamm. 2018 August:1–11. doi:10.1080/09273948.2018.1489061.
  • Gunasekeran DV, Agrawal R, Agarwal A, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis. Retina (Philadelphia, PA). 2018 April. doi:10.1097/IAE.0000000000002194.
  • Nohr EA, Liew Z. How to investigate and adjust for selection bias in cohort studies. Acta Obstet Gynecol Scand. 2018;97(4):407–416. doi:10.1111/aogs.13319.
  • Agrawal R, Kee AR, Ang L, et al. Tuberculosis or sarcoidosis: opposite ends of the same disease spectrum? Tuberculosis (Edinb). 2016;98:21–26. doi:10.1016/j.tube.2016.01.003.
  • Goletti D, Lindestam Arlehamn CS, Scriba TJ, et al. Can we predict tuberculosis cure? What tools are available? Eur Respir J. 2018;52:5. doi:10.1183/13993003.01089-2018.
  • Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236. doi:10.1159/000078612.
  • The Multicenter Uveitis Steroid Treatment (MUST) trial: rationale, design and baseline characteristics. Am J Ophthalmol. 2010;149(4):550–561.e10. doi:10.1016/j.ajo.2009.11.019.
  • Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388(10050):1183–1192.doi:10.1016/S0140-6736(16)31339-3.
  • Agrawal R, Testi I, Mahajan S, et al. Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis. Ophthalmology. 2020 January. doi:10.1016/j.ophtha.2020.01.008.
  • Agarwal A, Agrawal R, Gunasekaran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends. Ocul Immunol Inflamm. 2017 December:1–9. doi:10.1080/09273948.2017.1406529.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.